Susan Cu-Uvin

Summary

Affiliation: Rhode Island Hospital
Country: USA

Publications

  1. pmc Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR
    William T Seaman
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA
    Virol J 7:194. 2010
  2. ncbi request reprint Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
    S Cu-Uvin
    Brown University, Providence, RI, USA
    AIDS 14:415-21. 2000
  3. ncbi request reprint Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection
    Susan Cu-Uvin
    Brown University, Providence, RI, USA
    Clin Infect Dis 34:1406-11. 2002
  4. doi request reprint Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load
    Susan Cu-Uvin
    Division of Infectious Diseases, Department of Medicine, Miriam Hospital Alpert Medical School, Brown University, Providence, Rhode Island 02906, USA
    AIDS 24:2489-97. 2010
  5. ncbi request reprint Brown's involvement in the health of less developed countries
    Susan Cu-Uvin
    Immunology Center, Miriam Hospital, Providence, RI 02906, USA
    Med Health R I 90:340-1. 2007
  6. ncbi request reprint Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract
    S Cu-Uvin
    Department of Obstetrics and Gynecology, Brown University, Providence, RI 02906, USA
    Clin Infect Dis 33:894-6. 2001
  7. ncbi request reprint Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months
    Susan Cu-Uvin
    The Miriam Hospital, Brown Medical School, Providence, Rhode Island, USA
    J Acquir Immune Defic Syndr 42:584-7. 2006
  8. ncbi request reprint Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
    J Low Genit Tract Dis 11:90-7. 2007
  9. pmc Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load
    Kartik K Venkatesh
    Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, RI, USA
    J Womens Health (Larchmt) 22:330-8. 2013
  10. pmc Genital tract leukocytes and shedding of genital HIV type 1 RNA
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA
    Clin Infect Dis 47:1216-21. 2008

Research Grants

Detail Information

Publications64

  1. pmc Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR
    William T Seaman
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA
    Virol J 7:194. 2010
    ..While other quantitative PCR (qPCR) assays detect oncogenic HPV, there is no single tube assay distinguishing the most frequent oncogenic types and the most common types found in warts...
  2. ncbi request reprint Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
    S Cu-Uvin
    Brown University, Providence, RI, USA
    AIDS 14:415-21. 2000
    ..To compare the effect of initiating HAART on the timing of HIV-1 RNA suppression in the blood plasma and genital tract among antiretroviral-naïve women...
  3. ncbi request reprint Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection
    Susan Cu-Uvin
    Brown University, Providence, RI, USA
    Clin Infect Dis 34:1406-11. 2002
    ..HIV infection does not make a woman more likely to have prevalent, incident, or persistent or recurrent trichomoniasis...
  4. doi request reprint Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load
    Susan Cu-Uvin
    Division of Infectious Diseases, Department of Medicine, Miriam Hospital Alpert Medical School, Brown University, Providence, Rhode Island 02906, USA
    AIDS 24:2489-97. 2010
    ..Few studies have assessed longitudinal genital tract HIV-1 shedding. We determined patterns of genital tract HIV-1 RNA shedding over time among women with suppressed plasma viral load (PVL) on antiretroviral treatment...
  5. ncbi request reprint Brown's involvement in the health of less developed countries
    Susan Cu-Uvin
    Immunology Center, Miriam Hospital, Providence, RI 02906, USA
    Med Health R I 90:340-1. 2007
  6. ncbi request reprint Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract
    S Cu-Uvin
    Department of Obstetrics and Gynecology, Brown University, Providence, RI 02906, USA
    Clin Infect Dis 33:894-6. 2001
    ..Bacterial vaginosis was significantly associated with HIV-1 RNA expression in the female genital tract of HIV-infected women...
  7. ncbi request reprint Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months
    Susan Cu-Uvin
    The Miriam Hospital, Brown Medical School, Providence, Rhode Island, USA
    J Acquir Immune Defic Syndr 42:584-7. 2006
    ..To determine the patterns and predictors of genital tract HIV-1 RNA levels during a 36-month period...
  8. ncbi request reprint Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
    J Low Genit Tract Dis 11:90-7. 2007
    ..To describe outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV...
  9. pmc Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load
    Kartik K Venkatesh
    Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, RI, USA
    J Womens Health (Larchmt) 22:330-8. 2013
    ....
  10. pmc Genital tract leukocytes and shedding of genital HIV type 1 RNA
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA
    Clin Infect Dis 47:1216-21. 2008
    ..We sought to determine whether the presence of inflammatory cells in the vagina is associated with the presence of genital tract HIV type 1 (HIV-1) RNA...
  11. pmc Effect of trichomoniasis therapy on genital HIV viral burden among African women
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Women and Infants Hospital Alpert Medical School at Brown University, Providence, RI 02905, USA
    Sex Transm Dis 39:638-42. 2012
    ..Our objective was to test the hypothesis that treatment for trichomoniasis among HIV-infected women not taking antiretrovirals in South Africa would be associated with decreased HIV genital shedding...
  12. pmc Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis
    Caroline Mitchell
    Department of Obstetrics and Gynecology, University of Washington, P O Box 356460, Seattle, WA 98195, USA
    Infect Dis Obstet Gynecol 2009:236919. 2009
    ..Fastidious bacteria have been associated with bacterial vaginosis (BV) using PCR methods. We assessed the prevalence of these bacteria in HIV-1 infected women and their relationship with vaginal pH and shedding of HIV-1 RNA...
  13. doi request reprint High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding
    Regan N Theiler
    Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77550 0587, USA
    Obstet Gynecol 115:1150-8. 2010
    ..To evaluate the presence of and estimate risk factors for reactivation of latent high-risk human papillomavirus (HPV) cervical infection in human immunodeficiency virus (HIV)-infected and HIV-uninfected women...
  14. pmc HIV infection in refugees: a case-control analysis of refugees in Rhode Island
    Curt G Beckwith
    The Miriam Hospital, Providence, Rhode Island, USA
    Int J Infect Dis 13:186-92. 2009
    ..We performed a retrospective case-control analysis of HIV-infected refugees in order to characterize their co-morbidities, baseline HIV characteristics, and longitudinal care compared to HIV-infected non-refugees...
  15. ncbi request reprint Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence
    Joseph I Harwell
    Brown University, Providence, RI, USA
    AIDS 17:1990-3. 2003
    ..6 log10 copies/ml) CVL HIV-1-RNA levels by 3 months and undetectable plasma HIV-1-RNA levels by 6 months. The mean CD4 cell increase was 76 cells/mm3. DOT appears effective and may reduce infectiousness in this high-risk population...
  16. doi request reprint Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)
    Erna Milunka Kojic
    Department of Medicine, Division of Infectious Diseases, Miriam Hospital, The Alpert Medical School of Brown University, Providence, RI 02906, USA
    Sex Transm Dis 38:253-9. 2011
    ..Human papillomavirus (HPV) infection of the cervix and related abnormal cervical cytology in HIV-infected women has been well described. Little is known about anal HPV infection in HIV-infected women...
  17. pmc In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Alpert School of Medicine, Brown University Women and Infants Hospital, Providence, RI, USA
    Am J Obstet Gynecol 207:65.e1-10. 2012
    ..To evaluate whether cervicovaginal secretions inhibit HIV-1 infectivity in an in vitro model, and estimate concentration of immune mediators...
  18. ncbi request reprint Special care issues of women living with HIV-AIDS
    Erna Milunka Kojic
    Division of Infectious Diseases, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02806, USA
    Infect Dis Clin North Am 21:133-48, ix. 2007
    ..More women are expected to reach menopause. Health care providers should be aware of these unique needs of HIV-infected women...
  19. pmc Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women
    Phyllis Losikoff
    Department of Pediatrics, Division of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA
    Infect Dis Obstet Gynecol 2007:92307. 2007
    ..Trends in cytokine levels were similar for HIV-infected and HIV-uninfected women. BV in these women was associated with significantly higher concentrations of genital tract IL-8 which decreased 2.4 fold when BV was cleared...
  20. doi request reprint Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy
    Awewura Kwara
    Miriam Hospital, Providence, Rhode Island 02906, USA
    Clin Infect Dis 46:719-25. 2008
    ....
  21. ncbi request reprint Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Timothy P Flanigan
    Department of Medicine, Brown University, Providence, RI 02906, USA
    Clin Infect Dis 45:1499-501. 2007
  22. pmc Pregnancy-induced changes in immune protection of the genital tract: defining normal
    Brenna L Anderson
    Division of Maternal Fetal Medicine, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA
    Am J Obstet Gynecol 208:321.e1-9. 2013
    ..The objective of this study was to define immune changes in lower genital and systemic immunity associated with normal pregnancy...
  23. ncbi request reprint A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide
    Joseph I Harwell
    Brown University, The Miriam Hospital, Providence, Rhode Island 02906, USA
    J Womens Health (Larchmt) 12:255-9. 2003
    ..We undertook a pilot study of a buffering vaginal microbicide in the treatment of BV...
  24. pmc The changing face of HIV in pregnancy in Rhode Island 2004-2009
    Jacqueline Firth
    Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA
    Infect Dis Obstet Gynecol 2012:895047. 2012
    ....
  25. ncbi request reprint HIV and menopause: a review
    Erna Milunka Kojic
    Department of Medicine, Division of Infectious Diseases, The Miriam Hospital, Brown University, Providence, Rhode Island 02906, USA
    J Womens Health (Larchmt) 16:1402-11. 2007
    ..Likewise, there is a need for a better understanding of the prevalence and manifestations of depression among these women...
  26. pmc Infant outcomes after maternal antiretroviral exposure in resource-limited settings
    Karin Nielsen-Saines
    Department of Pediatrics, Division of Infectious Diseases, David Geffen UCLA School of Medicine, MDCC 22 442, 10833 LeConte Ave, Los Angeles, CA 90095, USA
    Pediatrics 129:e1525-32. 2012
    ..The impact of maternal antiretrovirals (ARVs) during pregnancy, labor, and postpartum on infant outcomes is unclear...
  27. doi request reprint Antiretroviral-induced hepatotoxicity presenting as nonreassuring fetal testing
    Nadine Kassis
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    Obstet Gynecol 116:515-7. 2010
    ..Treatment can cause mitochondrial dysfunction, leading to liver damage and acidosis. Early diagnosis is essential to improve outcome...
  28. ncbi request reprint Effect of the menstrual cycle on virological parameters
    Susan Cu-Uvin
    Brown University, Providence, RI, USA
    J Acquir Immune Defic Syndr 38:S33-4. 2005
  29. ncbi request reprint Update: human papillomavirus infection remains highly prevalent and persistent among HIV-infected individuals
    Erna Milunka Kojic
    Department of Medicine, Division of Infectious Diseases, The Miriam Hospital, and Department of Obstetrics and Gynecology, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island 02906, USA
    Curr Opin Oncol 19:464-9. 2007
    ....
  30. doi request reprint Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women
    Kartik K Venkatesh
    Department of Obstetrics and Gynecology, Alpert Medical School, Brown University, Providence, RI 02912, USA
    Am J Reprod Immunol 69:68-73. 2013
    ..The reasons for these divergent results still remain to be fully elucidated. Understanding biological factors that affect HIV susceptibility provide opportunities to identify prevention strategies to reduce the risk of HIV acquisition...
  31. doi request reprint Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology
    Lori A Boardman
    Women and Infants Hospital of Rhode Island and The Miriam Hospital, Brown University, Providence, Rhode Island, USA
    Obstet Gynecol 112:238-43. 2008
    ..To compare the prevalence of cervical intraepithelial neoplasia (CIN) 2 or worse in a cohort of human immunodeficiency virus (HIV)-positive and HIV-negative women with mildly abnormal cervical cytology...
  32. pmc HIV-1 seroprevalence and awareness of mother-to-child transmission issues among women seeking antenatal care in Tamil Nadu, India
    Jacqueline Firth
    Department of Medicine, Warren Alpert Medical School at Brown University, Providence, RI, USA
    J Int Assoc Physicians AIDS Care (Chic) 9:206-13. 2010
    ..Conclusions: There is a need to educate South Indian women about HIV to give them information and the means to protect themselves and their unborn children from acquiring HIV...
  33. ncbi request reprint Antiretroviral rounds. Can you be positive that she's positive?
    Susan Cu-Uvin
    Brown University School of Medicine, Providence, Rhode Island, USA
    AIDS Clin Care 16:98-9. 2004
  34. pmc Clinical parameters essential to methodology and interpretation of mucosal responses
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Women and Infant s Hospital, Alpert Medical School at Brown University, 101 Dudley Street, Providence, RI 02905, USA
    Am J Reprod Immunol 65:352-60. 2011
    ..Important topics to consider include the method and source of sample collection, the individual patient characteristics, and in the case of recruitment of HIV-infected women, HIV disease characteristics...
  35. ncbi request reprint Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1
    Selvi B Williams
    Department of Medicine, Brown University School of Medicine, Providence, RI 02906, USA
    Clin Infect Dis 35:611-7. 2002
    ..0474) compared with women who did not have bacterial vaginosis. Enhanced understanding of correlates of mucosal immunity to HIV-1 may assist in the design of vaccine strategies or in the prevention of vertical transmission of HIV-1...
  36. doi request reprint Pregnancy and optimal care of HIV-infected patients
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, Rhode Island, USA
    Clin Infect Dis 48:449-55. 2009
    ..In these settings, exclusive breast-feeding for 6 months is recommended to reduce the risk of postnatal transmission...
  37. doi request reprint Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women
    Brenna L Anderson
    Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Providence, RI, USA
    Acta Obstet Gynecol Scand 90:510-5. 2011
    ..The objective of this study was to examine the impact of changes in individual microflora on genital immunity among low-risk pregnant women in early pregnancy...
  38. pmc Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz
    Monica L Carten
    Division of Infectious Diseases, University of Colorado Denver, Aurora, CO, USA
    Infect Dis Obstet Gynecol 2012:137192. 2012
    ..Compare the Plan B levonorgestrel (LNG) area under the concentration- time curve (AUC(12)) prior to and with efavirenz (EFV). Design. Prospective, open-label, single-arm, equivalence study...
  39. pmc Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya
    Hillary Mabeya
    United States Agency for International Development Academic Model Providing Access to Healthcare Partnership, Moi University School of Medicine, Eldoret, Kenya
    J Low Genit Tract Dis 16:92-7. 2012
    ..This study aimed to determine the accuracy of visual inspection with acetic acid (VIA) versus conventional Pap smear as a screening tool for cervical intraepithelial neoplasia/cancer among human immunodeficiency virus (HIV)-infected women...
  40. ncbi request reprint The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions
    Patricia S Reichelderfer
    J Infect Dis 186:726-8; author reply 728-9. 2002
  41. doi request reprint HIV and obstetric complications and fetal outcomes in Vellore, India
    Jessie Lionel
    Department of Obstetrics and Gynaecology, Christian Medical College, Vellore, India
    Trop Doct 38:144-6. 2008
    ..001). HIV prophylaxis and optimal prenatal care should be a priority for HIV-infected pregnant women in resource-limited countries...
  42. ncbi request reprint Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women
    Raphael P Viscidi
    Johns Hopkins Hospital, Blalock Room 1105, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Cancer Epidemiol Biomarkers Prev 14:283-8. 2005
    ..0-2.0). The lack of a protective immune effect from natural infection is most likely due to the low level of antibody elicited by natural HPV infection and/or the potential for reactivation of HPV, especially in HIV-positive women...
  43. ncbi request reprint Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity
    Ann Duerr
    National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health HIV Section, Centers for Disease Control and Prevention, Mailstop K 34, 4770 Buford Highway NE, Atlanta, GA 30341 3717, USA
    Obstet Gynecol 101:548-56. 2003
    ..To examine risk factors for vulvovaginal candidiasis among women with or at risk for human immunodeficiency virus (HIV) infection...
  44. ncbi request reprint Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus
    Sioban D Harlow
    Department of Epidemiology, University of Michigan, Ann Arbor, USA
    Am J Obstet Gynecol 188:881-6. 2003
    ..The purpose of this study was to evaluate the impact of substance use and psychotherapeutic medications on menstrual characteristics in women who are human immunodeficiency virus seropositive and seronegative...
  45. ncbi request reprint Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women
    Paula Schuman
    Wayne State University School of Medicine, Detroit, Michigan 48109, USA
    J Infect Dis 188:128-36. 2003
    ..SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated...
  46. ncbi request reprint Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women
    Howard D Strickler
    Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Natl Cancer Inst 95:1062-71. 2003
    ..To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS)...
  47. ncbi request reprint The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Michael J Silverberg
    Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
    Sex Transm Dis 29:427-35. 2002
    ..HIV infection and associated immunodeficiency are known to alter the course of human papillomavirus (HPV) infections and of associated diseases...
  48. ncbi request reprint Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women
    Sherene S Min
    Schools of Medicine, University of North Carolina, Chapel Hill 27599 7360, USA
    J Acquir Immune Defic Syndr 37:1577-80. 2004
    ..Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary...
  49. ncbi request reprint Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle
    Pamela A Kozlowski
    GI Cell Biology Research Laboratory, Children s Hospital, and Department of Pediatrics, Harvard University, Boston, MA 02115, USA
    J Immunol 169:566-74. 2002
    ..However, induction of genital tract and rectal Ab responses of the magnitude generated by local V-FP(imm) or R(imm) will likely require administration of comparably high nasal vaccine dosages...
  50. ncbi request reprint Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract
    Michael Newstein
    J Acquir Immune Defic Syndr 38:364-6. 2005
  51. pmc Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection
    Beth C Tohill
    Centers for Disease Control and Prevention, National Center for Chronic Disease and Public Health Prevention, Division of Nutrition and Physical Activity, Atlanta, GA 30341, USA
    Infect Dis Obstet Gynecol 12:121-6. 2004
    ..The proposed profiles from the Gram stain reflect the morphotypic categories describing vaginal flora that may enable clearer elucidation of gynecologic and obstetric outcomes in various populations...
  52. ncbi request reprint Protease inhibitor use in 233 pregnancies
    Anne B Morris
    Community Research Initiative of New England, Springfield, MA 01107, USA
    J Acquir Immune Defic Syndr 40:30-3. 2005
    ..Prospective trials employing HAART during pregnancy are ongoing...
  53. ncbi request reprint Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
    Jill E Koshiol
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Int J Cancer 119:1623-9. 2006
    ..57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus...
  54. ncbi request reprint Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus
    Denise J Jamieson
    Womens Health and Fertility Branch, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Obstet Gynecol 107:1023-8. 2006
    ..To compare the incidence of vulvar, vaginal, and perianal intraepithelial neoplasia among human immunodeficiency virus (HIV)-infected women with a group of well-matched high-risk HIV-uninfected controls...
  55. ncbi request reprint Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women
    Jill Koshiol
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, USA
    Am J Epidemiol 164:176-83. 2006
    ..93, 95% CI: 0.68, 1.26) women. HPV clearance did not appear to vary by amount or duration of smoking. Smoking did not modify overall clearance but was associated with lower high-risk HPV clearance in HIV-seronegative women...
  56. ncbi request reprint Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068
    Jeffrey M Jacobson
    Beth Israel Medical Center and Albert Einstein College of Medicine, New York, NY 10003, USA
    J Infect Dis 194:623-32. 2006
    ....
  57. ncbi request reprint Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection
    Denise J Jamieson
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 186:21-7. 2002
    ....
  58. ncbi request reprint Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection
    Beth C Tohill
    Centers for Disease Control and Prevention, National Center for Chronic Disease and Public Health Prevention, Division of Nutrition and Physical Activity and Division of Reproductive Health, Atlanta, GA 30341, USA
    Am J Clin Nutr 85:1327-34. 2007
    ..This relation among HIV, nutrition, and gynecological conditions is complex and has rarely been investigated...
  59. ncbi request reprint Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome
    Nancy M Brim
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    AIDS Read 17:322-8, C3. 2007
    ....
  60. ncbi request reprint Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women
    Raphael P Viscidi
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Infect Dis 187:194-205. 2003
    ..Despite the higher prevalence of HPV infection in this group, most HIV-positive women are able to control HPV-16 replication at the cervix, and reactivation, if it occurs, is not very common...
  61. ncbi request reprint Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy
    Pangaja Paramsothy
    Contraceptive Research and Development CONRAD Program, Arlington, VA, USA
    J Acquir Immune Defic Syndr 35:484-91. 2004
    ..To determine the frequency of and risk factors for abnormal vaginal Papanicolaou smears in HIV-infected women after hysterectomy...
  62. ncbi request reprint Effect of HIV infection on atypical squamous cells of undetermined significance
    Ann Duerr
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Clin Infect Dis 42:855-61. 2006
    ..Detection of atypical squamous cells of undetermined significance (ASCUS) is a cervical cytologic finding that is suggestive but not definitive of squamous intraepithelial lesions (SILs)...
  63. ncbi request reprint T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women
    Alison J Quayle
    Department of Immunology, Microbiology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    J Acquir Immune Defic Syndr 44:292-8. 2007
    ..The mucosal lymphocyte population is the largest in the body, and the gastrointestinal compartment has been well characterized in HIV infection. Much less is known about the effects of HIV on the genital tract...
  64. ncbi request reprint Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells
    Marie Larsson
    Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, NY, USA
    AIDS 16:171-80. 2002
    ..To utilize the potent antigen-presenting capacity of mature dendritic cells (MDC) in order to develop a rapid, sensitive method for quantifying antigen-specific CD8 T cells present at low frequency in peripheral blood...

Research Grants14

  1. ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMEN
    Susan Cu Uvin; Fiscal Year: 2007
    ..These findings underscore the risk of spreading resistant HIV-1 variants sexually as well as perinatally. With my research, I hope to be able to help contribute to the work on HIV treatment and prevention. ..
  2. ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMEN
    Susan Cu Uvin; Fiscal Year: 2007
    ..We also propose to enroll women who have undergone total hysterectomy to assess HIV dynamics in the vagina. ..
  3. ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMEN
    Susan Cu Uvin; Fiscal Year: 2001
    ..HIV load will be measured in plasma and cervicovaginal secretions by NASBA. HIV resistance phenotype will be determined by combined approaches of isolate phenotyping and genotyping of proviral DNA predominately in viral isolates. ..